Composition, structure and packing

Combined medication. Contains acetylsalicylic acid, glycine, sodium bicarbonate, anhydrous citric acid.

Alka-Prim released in the form of effervescent tablets of 2,8 g

Pharmacological action

Tablets Alka-note anti-inflammatory, antipyretic, analgesic effect. Prevents thrombosis. Neutralizes free hydrochloric acid in the stomach, which reduces the irritating effect of the drug on the mucous membranes of the gastrointestinal tract

pain syndrome is weak and medium intensity (headache, myalgia, arthralgia, etc.)
hyperthermia (including when "cold" diseases, viral infections),
dyspepsia (including heartburn, burning in the epigastrium, stomachalgia, including those caused by overeating or abuse of ethanol).

Dosage regimen

Adults appoint 1-2 tablets Alka-ca 3-4 times a day, with headache in combination with digestive disorders, caused by an error in the diet - a single dose 1-2 tablets.

Before taking a pill Alka-prima should be dissolved in 3 / 4 cup warm water.

Side effect

On the part of the SSA and the hemostatic system: bleeding, changes in the cellular composition of blood, collapse.

On the part of the digestive system: nausea, vomiting, decreased appetite, abdominal pain.

Allergic reactions: urticaria, angioedema, bronchospasm, shock (until loss of consciousness), tearing, allergic rhinitis.

predisposition to bleeding;
erosive and ulcerative lesions in the gastrointestinal stage of exacerbation;
deficiency of glucose-6-phosphate dehydrogenase;
marked disturbances of water-electrolyte metabolism and acid-base balance;
Hypersensitivity to the drug's components.

Pregnancy and lactation

The drug Alka-Prim contraindicated in pregnancy.

Do not take Alka-Prim and the postpartum period. If you want to use the drug for a long time and in high doses during lactation must decide whether to breast-feed.


Do not give tablets Alka-note children under 14 years of pyretic disease. By combining this drug with drugs valproic acid (anticonvulsant), anticoagulants or cephalosporins increased risk of bleeding, with simultaneous application with gipoglikemiziruyuschimi drugs (derivatives sulfanilmocheviny) is increased hypoglycemic effect.


Symptoms: noise and ringing in the ears.

Treatment: symptomatic.

Drug Interactions

Enhances the effect of oral anticoagulants and hypoglycemic drugs, insulin, methotrexate, other NSAIDs, GCS, valproic acid, ethanol. Reduces effect sulfinpirazon, diflunizala, fenoprofena, ibuprofen, indomethacin, piroxicam, naproxen, sulindaka, as well as drugs that block tubular secretion. Myelotoxic drugs increase the expression gematotoksichnosti drug.

Terms and Conditions of storage

Store in a dry place at temperatures not above 25 ° C.

Expiration date - 2 years.